Search

everythinglearnresearchcommunity

for

Search:↓

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Hirsutism in young girls can have causes other than PCOS, so diagnoses should be reassessed if treatments don't work.

Most women with hyperandrogenism first show acne, and skin conditions like hirsutism and acanthosis nigricans are good indicators of the condition.

Women with congenital adrenal hyperplasia showed no prostatic growth.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Accurate diagnosis of hyperandrogenism, especially PCOS, is crucial for managing fertility and metabolic risks in women.

Women with androgenetic alopecia often have other symptoms of high androgen levels, requiring further hormone testing.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Changing estrogen levels during menopause might affect genes related to body rhythms and cause increased hair loss.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Hirsutism in females is complex, often linked to tumors, and requires more research for better treatment.

Topical estrogen treatments did not change hair growth in certain mouse strains, questioning previous findings on their role in hair growth control.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Hyperandrogenism does not affect young women's sexual function.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Estrogen affects hair growth, and GPER-1 levels might help identify hair loss types.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Ovarian tumors should be considered when postmenopausal women show signs of virilization.